Insula Neuromodulation for Chronic Neuropathic Pain
RecruitingNCT05404581Phase: NAStarted 2022-11-01
Summary
This study will comprehensively investigate the insula as a brain target for neuromodulation to treat chronic neuropathic pain.
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
80 Years
Inclusion Criteria: 1. Men and women, between 18 and 80 years, inclusive 2. Subjects who are able and willing to give consent and able to attend all study visits 3. The pain is: * chronic with ≥6 month duration * severe is defined as: 'average' NPRS score of ≥ 5 out of 10 at current visit an
Locations
University of Virginia
Charlottesville, Virginia, United States
Interested in participating? View the full study details on ClinicalTrials.gov:
View on ClinicalTrials.gov →